Profound Medical Corp. Equity Offering

Profound Medical Corp. announced a registered direct offering of 5,142,870 common shares at $7.00 per share, for aggregate gross proceeds of $36 million. The offering is expected to close on or about December 22, 2025. The company plans to use the proceeds for sales and marketing expansion, working capital, research and development, strategic transactions, and general corporate purposes. The shares were offered under a Form S-3 registration statement. The company also entered into a placement agency agreement with Konik Capital Partners, LLC, agreeing to pay a 5.0% fee and reimburse expenses up to $100,000. Additionally, Profound Medical Corp. intends to conduct a private placement of up to 571,428 common shares at $7.00 per share, for up to $4 million in gross proceeds, to certain Canadian purchasers. This private placement is expected to close on or prior to December 30, 2025, and is subject to regulatory approvals.